While silencing of vimentin in melanoma cells can reverse the EMT phenotype, in part by promoting down-regulation of the protein kinase Axl that is involved in cell motility, forced expression of vimentin in tumor cells lacking this protein is sufficient to trigger the switch from epithelial to mesenchymal phenotype. Here, VIM is linked to neoplasm.